Quarterly report pursuant to Section 13 or 15(d)

Segment Disclosures

v3.19.1
Segment Disclosures
 3 Months Ended
Mar. 31, 2019
Segment Reporting [Abstract]  
Segment Disclosures
Segment Disclosures
 
The Company has two reportable segments: EksoHealth (also referred to as the medical devices segment) and EksoWorks (also referred to as the industrial devices segment). The EksoHealth segment designs, engineers, manufactures, and sells exoskeletons for applications in the medical markets. The EksoWorks segment designs, engineers, manufactures, and sells exoskeleton devices to allow able-bodied users to perform heavy duty work for extended periods.
 
The Company evaluates performance and allocates resources based on segment gross profit margin. The reportable segments are each managed separately because they serve distinct markets, and one segment provides a service and the others manufacture and distribute unique products. The Company does not consider net assets as a segment measure and, accordingly, assets are not allocated.
 
Segment reporting information is as follows:
 
EksoHealth
 
EksoWorks
 
Total
Three months ended March 31, 2019
 

 
 

 
 

Revenue
$
2,814

 
$
802

 
$
3,616

Cost of revenue
1,300

 
717

 
2,017

Gross profit
$
1,514

 
$
85

 
$
1,599

 
 
 
 
 
 
Three months ended March 31, 2018
 

 
 

 
 

Revenue
$
2,122

 
$
396

 
$
2,518

Cost of revenue
1,387

 
364

 
1,751

Gross profit
$
735

 
$
32

 
$
767


 
Geographic information for revenue based on location of customers is as follows:
 
Three Months Ended March 31,
 
2019
 
2018
United States
$
2,371

 
$
1,353

All Other
1,245

 
1,165

 
$
3,616

 
$
2,518